Cellares, the world’s first Integrated Development and Manufacturing Organization (IDMO), and a leader in automated cell therapy manufacturing, has appointed Ossama Eissa, former executive...
Crossroads Treatment Centers (Crossroads), a leading provider of substance use disorder (SUD) treatment, announced the appointment of Nick Sulaiman, a highly seasoned healthcare executive,...
Nutcracker Therapeutics, Inc., a pioneering biotechnology company dedicated to enabling transformative RNA therapies through its proprietary technology platform, announced its new contract research, development,...
General Galactic, a pioneer in fossil-free fuel generation technology, announced the closing of an $8 million seed funding round, bringing the total investment in...
